What is it about?
TNF inhibitors use-associated rises in hepatic enzymes were determined compared to pre-treatment but the mean values remained within normal limits.
Featured Image
Why is it important?
Considering the cases in the literature, in daily practice patients treated for ankylosing spondylitis with TNF inhibitors, must be carefully monitored for liver function before treatment and at follow-up.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations. Patients treated for ankylosing spondylitis with TNF inhibitors, have a risk of hepatic flare. So doctors who treat patients with TNF inhibitors can use this data.
Dr Arif Mansur Cosar
Karadeniz Teknik Universitesi
Read the Original
This page is a summary of: Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study, International Journal of Rheumatic Diseases, February 2014, Wiley,
DOI: 10.1111/1756-185x.12311.
You can read the full text:
Contributors
The following have contributed to this page
